Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy.
about
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- VinorelbineOvercoming therapeutic resistance in glioblastoma: the way forwardGenomics, Endoscopy, and Control of Gastroesophageal Cancers: A Perspective.A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapyThe role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcomeAnalysis of Paired Primary-Metastatic Hormone-Receptor Positive Breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal ResistanceMultiple region whole-exome sequencing reveals dramatically evolving intratumor genomic heterogeneity in esophageal squamous cell carcinoma.DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolutionDifferential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapyMultiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolismPan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations.Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1.Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions.Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinomaReduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma.TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer.Prevalence and Significance of HMGA2 Expression in Esophageal Adenocarcinoma.Metastasis as an evolutionary process.Massive parallel sequencing of solid tumours - challenges and opportunities for pathologists.New paradigms in clonal evolution: punctuated equilibrium in cancer.Lesion-Directed Therapies and Monitoring Tumor Evolution Using Liquid Biopsies.The Role of Aneuploidy in Cancer Evolution.Natural Selection in Cancer Biology: From Molecular Snowflakes to Trait Hallmarks.The evolution of tumour phylogenetics: principles and practice.Chromosomal Instability as a Driver of Tumor Heterogeneity and Evolution.Treatment-Induced Mutagenesis and Selective Pressures Sculpt Cancer Evolution.Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.The genetics of gastroesophageal adenocarcinoma and the use of circulating cell free DNA for disease detection and monitoring.Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors.Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.Genomic comparison of esophageal squamous cell carcinoma and its precursor lesions by multi-region whole-exome sequencing.Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient.Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal Evolution.APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability.Editorial on role of p53 in esophageal cancer from a meta-analysis of 16 studies by Fisher et al.Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma.Utility of Genomic Analysis In Circulating Tumor DNA from Patients with Carcinoma of Unknown Primary.
P2860
Q28554790-75A6F1E1-2338-41ED-B628-B9DC07E8E85EQ29248396-F0275F85-417A-4AA8-AE2A-741CB03E46C2Q33600507-C69306D6-75B4-4800-B921-A55B181AAD49Q33751457-85F03AE5-D3E1-4154-AECB-4303CF72BA0EQ33913152-420E8E54-5FDF-48A0-AF55-606C7A79463EQ36022154-5373826A-21C0-4F9F-B13D-14971C5870C6Q36350011-F73E2E84-9405-439B-A11D-EF03F45095F7Q36603133-457821C2-F3A1-4912-A6FA-7D2375BD4F21Q36768782-C19267AA-9970-4532-8914-814F478CF9BCQ36891604-6B97B35B-DA7D-4573-94BB-87C459D3DCBFQ36962873-2FE781A3-5417-4BAD-B888-4C4A28B6B876Q37007851-29C56971-6177-4724-ADE9-848F583DA088Q37130372-7B13E4DE-937B-4803-B888-3466695FCF2BQ37236624-3DBD3D89-BF3D-4577-A07E-3B2FA32F107BQ37395490-51F20DF9-017C-45F9-9D86-2D6DE158A0FFQ37452434-A1807E2F-D1B6-4778-9C60-604097E73F7CQ37536791-6B75A6A9-FEE7-4070-AB68-6741ADBD3755Q37620902-B117D6C5-AFF7-48DC-A64D-F872D9ED9B96Q38677878-F0F72868-2EF1-46CB-9572-6D622B8F4452Q38819909-6635060F-27F2-46A5-87AB-DBAE226E8F8AQ38828314-42CC3E12-1657-4907-A19E-2ABAFA48187BQ38860529-DE80D3AD-9E55-4F7D-B4A1-CF003184BD0EQ39047616-9F4FC387-CD9A-453B-A8B7-6F2E0DE270A6Q39066291-AB21C160-75F1-47AA-97DF-69DE7A568CDAQ39114006-AC889DD8-DD2B-4B5C-B62C-8AEC18FAB1BDQ39132571-1D9E843C-6F14-4A98-ABAC-D82A6D8F88FDQ39141464-033F939A-B9D1-498E-BB99-E80F89BC8E60Q39176607-8A75C817-82D9-48C9-9205-41BF9468BF87Q39182541-CE1D78F5-FF4E-4C79-8721-CB7F7BB212FBQ39183864-0273098F-798D-4DE5-B478-F1EAFA55666DQ39341353-C3E724F7-343E-43EE-9577-B8C2EDEDF93CQ40269605-5DEB964E-B0F8-4204-B7EA-1F0F7628D25BQ41198823-E48A0AEC-2703-4FD6-90E4-7B8950AC3FEEQ41571576-AB5CBA3A-92AF-422F-B807-EFDDA7116671Q42131289-8B3733C5-AF62-4760-84FD-0178827E1BB6Q42322723-B2309B85-CF42-4B02-9334-A950AC566C9CQ42332720-E841BFCF-037C-4218-AEF5-4DAAA5AE7FEEQ46129222-F148F38D-1066-4C6F-AC29-1DF4C645FCCFQ46204388-137E0C3D-E05E-4564-8740-586174B9314EQ46296816-94B6EDD8-B65B-4ACF-A173-14F0F9F9AB8D
P2860
Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tracking the genomic evolution ...... ough neoadjuvant chemotherapy.
@ast
Tracking the genomic evolution ...... ough neoadjuvant chemotherapy.
@en
type
label
Tracking the genomic evolution ...... ough neoadjuvant chemotherapy.
@ast
Tracking the genomic evolution ...... ough neoadjuvant chemotherapy.
@en
prefLabel
Tracking the genomic evolution ...... ough neoadjuvant chemotherapy.
@ast
Tracking the genomic evolution ...... ough neoadjuvant chemotherapy.
@en
P2093
P2860
P50
P1433
P1476
Tracking the genomic evolution ...... ough neoadjuvant chemotherapy.
@en
P2093
Andrew Rowan
Benjamin Phillimore
Daniel Hochhauser
Gareth A Wilson
George B Hanna
Jennifer Biggs
Nik Matthews
Nima Abbassi-Ghadi
Nirupa Murugaesu
P2860
P304
P356
10.1158/2159-8290.CD-15-0412
P577
2015-05-23T00:00:00Z